Document is current
Any future updates will be listed below
-
Authors
MacDonald, Emma E.
Forbrigger, Zara N.
Ells, Brett
MacDonald, Tamara
Goldenberg, Neil A.
Kulkarni, Ketan
-
Funding
Funding for this research was provided by:
Canadian Pediatric Thrombosis & Hemostasis Network
IWK Health Centre
- License Information
-
More Information
Article History
Received: 11 March 2024
Accepted: 27 August 2024
First Online: 4 September 2024
Declarations
:
: Approved by the IWK research ethics board.
: Dr. Goldenberg receives research support and salary support from the National Institutes of Health, National Heart Lung and Blood Institute for clinical and translational investigation in venous thromboembolism in patients < 21 years old. He receives or has recently received (past 12 months) consultancy fees from Anthos Therapeutics, Bayer, and the University of Colorado-affiliated Academic Research Organization CPC Clinical Research for roles in clinical trial planning or oversight committees (e.g., advisory ctte; steering ctte; data and safety monitoring ctte) in pharmaceutical industry-sponsored pediatric multicenter clinical trials of antithrombotic agents. He also receives consultancy fees from Novartis for data and safety monitoring committee membership in multicenter clinical trials of an immunomodulatory agent. His employer, Johns Hopkins University, receives salary support on his behalf from Boehringer-Ingelheim for data coordinating center leadership for a pediatric antithrombotic multicenter prospective observational study.
